US Broker Ratings

Vanda Pharmaceuticals Inc. (VNDA)

⚠️ No article content returned.

..

Aura Biosciences, Inc. (AURA) Stock Analysis: Unpacking a 207% Potential Upside in Biotech

For investors seeking high-growth potential in the biotechnology sector, Aura Biosciences, Inc. (NASDAQ: AURA) presents a compelling opportunity. With a current market cap of $434.03 million and a notable potential..

Nerdy Inc. (NRDY) Investor Outlook: Unpacking a 25.74% Potential Upside Amidst Challenging Metrics

Investors eyeing Nerdy Inc. (NRDY), a technology company operating in the software application industry, are presented with a mixed bag of opportunities and challenges. With a current market cap of..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A 117% Upside Potential Beckons Investors

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing attention with its promising potential upside of 117%. Headquartered in Hayward, California, Benitec specializes in developing novel genetic medicines,..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a Potential 201% Upside with Promising Biotech Innovations

Candel Therapeutics, Inc. (NASDAQ: CADL) is a clinical-stage biopharmaceutical company that has caught the attention of investors with its innovative approach to cancer treatment and a remarkable potential upside of..

Shopify Inc. (SHOP) Stock Analysis: A Tech Powerhouse with a Revenue Growth Surge of 26.8%

Shopify Inc. (NYSE: SHOP), the Canadian commerce technology giant, continues to attract investor attention with its robust market presence and significant growth metrics. Operating in the ever-evolving technology sector, specifically..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Understanding the Market Dynamics and Future Outlook

Zhengye Biotechnology Holding Limited (ZYBT) is a Chinese company operating in the healthcare sector, specifically within the niche of drug manufacturing, focusing on specialty and generic veterinary vaccines. With a..

XOMA Royalty Corporation (XOMA) Stock Analysis: Uncovering a 149% Potential Upside in Biotech Royalties

Investors seeking opportunities in the biotechnology sector may find XOMA Royalty Corporation (NASDAQ: XOMA) to be a compelling prospect. With a potential upside of 149.39% based on analyst target prices,..

Porch Group, Inc. (PRCH) Investor Outlook: Navigating a Volatile Landscape with Strong Buy Ratings

Porch Group, Inc. (NASDAQ: PRCH) has captured the attention of investors with its innovative approach in the technology sector, specifically in the software applications industry. As the company continues to..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unraveling a 336% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approaches to treating infectious diseases and rare conditions...

Mereo BioPharma Group plc (MREO) Stock Analysis: Evaluating the 307% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO), a leading biopharmaceutical firm in the biotechnology sector, is capturing the attention of investors with its impressive potential upside of 307.53%. With a market..

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 77.78% Upside Potential in the Health Information Sector

Health Catalyst, Inc (NASDAQ: HCAT) is a key player in the rapidly evolving health information services industry. With a market capitalization of approximately $281.88 million, Health Catalyst is carving out..

Nyxoah SA (NYXH) Stock Analysis: Healthcare Innovator with a 72% Potential Upside

Nyxoah SA (NYSE: NYXH), a Belgium-based medical technology company, is attracting the attention of investors with its promising potential upside of 72.16%. Specializing in developing innovative solutions for obstructive sleep..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Assessing the 60.55% Upside Potential in the Healthcare Imaging Sector

Nano-X Imaging Ltd. (NASDAQ: NNOX) stands at the crossroads of innovation and opportunity within the healthcare sector, particularly in the medical devices industry. Based in Israel, the company has carved..

Chevron Corporation (CVX) Investor Outlook: Evaluating a 7.31% Upside Potential

Chevron Corporation (NYSE: CVX), a heavyweight in the energy sector, continues to command attention from investors with its robust market capitalization of $311.33 billion. As a leader in the integrated..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A 430% Upside Amidst Biotech Innovation

For investors looking at the healthcare sector, particularly in biotechnology, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling opportunity. As a clinical-stage biopharmaceutical company, Olema is at the forefront of..

UroGen Pharma Ltd. (URGN) Stock Analysis: A Biotech with High Growth Potential and an 84% Upside

UroGen Pharma Ltd. (NASDAQ: URGN), a biotechnology firm focused on urothelial and specialty cancers, is currently making waves in the healthcare sector. With a market capitalization of $862.12 million, UroGen..

Exxon Mobil Corporation (XOM) Stock Analysis: Unlocking a 13% Upside Potential for Investors

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, stands as a formidable player in the integrated oil and gas industry. With a commanding market capitalization of $473.76..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 70% Potential Upside in the Healthcare Sector

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $426.84 million, Cytek has been..

agilon health, inc. (AGL) Stock Analysis: Navigating a Potential 76.74% Upside in the Healthcare Sector

Investors in the healthcare sector are increasingly turning their attention to agilon health, inc. (NYSE: AGL), a company poised at the intersection of innovative healthcare delivery and financial volatility. Despite..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds